Established in 1807, The University of Maryland School of Medicine is the first public and the fifth oldest medical school in the United States, and the first to institute a residency training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland’s Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. While its tradition of excellence remains constant, the School of Medicine and its reputation for academic achievement continue to grow.
University of Maryland School of Medicine is one of the sites in the following two NIH networks: the Pharmacogenomics Research Network (PGRN) and Genomic Diagnosis and Personalized Therapy for Highly Penetrant Genetic Diabetes (IGNITE).
CAG is one of ten Centers for Emphasis of the Children’s Hospital of Philadelphia (CHOP). The CHOP Health Care Network includes over 50 practice sites throughout Pennsylvania and New Jersey which are live on the EpicCare EMR system. CHOP has assembled the components of the country’s largest pediatric integrated delivery system, supporting >1.1 million visits/year within the primary and specialty care networks, community-based inpatient pediatric and neonatal programs, a rehabilitation hospital, and a home care service. It provides acute- and well-care to patients in urban, rural, and suburban settings. CAG’s mission is to develop new and better ways to diagnose and treat children affected by both common and rare complex medical disorders. We aim to discover genetic causes for the most prevalent diseases of childhood including asthma, autism, diabetes, epilepsy, obesity, schizophrenia, and pediatric cancers. Ultimately, CAG’s objective is to generate new diagnostic tests and to guide physicians to the most appropriate therapies.
Group Health Cooperative with the University of Washington and the Fred Hutchinson Cancer Research Center (GHC/UW) as part of the Seattle eMERGE project aims to bring personal genomics to practice settings by taking advantage of the extensive electronic medical record (EMR) and biorepository of Group Health Cooperative (GHC), including a pharmacy database and longitudinal data on an aging population. The team has created a model for introducing genomics into clinical practice, performed successful needs assessment methods from eMERGE Phase I will engage stakeholders in guiding development of prototype EMR user interfaces in a clinical decision support format utilizing natural language processing. To disseminate eMERGE results and foster collaborations, GroupHealth leverages its advantage of leadership positions of the investigators (including partners within eMERGE, other consortia and the HMO Research network, especially the potential for developments supported by the NIH Director’s markers), improve the linking of high-throughput genomic methods to EMR data, and develop policies and practices for bringing individualized evidence-based medicine to communities.